Document:

Exhibit 10.9

                         FINDER'S and ADVISORY AGREEMENT

     THIS AGREEMENT (the "Agreement") made on this __ day of ____________,  2001
by and between  vSource1,  Inc.,  vSource1.com,  Inc., and vSource1 LLC and West
Park Capital,  Inc. and Scarborough Capital, Inc. (the "Finder") and, Nutrastar,
Inc. (otcbb:NTRA) (the "Issuer"or the "Company").

         THE PARTIES

1.1 Issuer, a ______________ corporation with its principal office at (Address)

     1.2 Finder, a Georgia  Subchapter S corporation,  with its principal office
at 40 Overby Lane, Atlanta, Georgia 30327.

     1.3 Each person executing this Agreement mutually represents that they have
full and complete  authority to do so and have been designated to do so by their
respective managers or Board of Directors.

2. THE AGREEMENT

     2.1 Issuer seeks to be  introduced  to one or more  businesses  or entities
together with such businesses' or entities' subsidiaries, affiliates and related
companies  (referred  to herein as the  "Target(s)")  that are  consistent  with
Issuer's  business and strategic  plans that Issuer could either  acquire all or
any portion of their capital securities or assets, or engage in a merger,  joint
venture  or other  business  arrangement  with  such  business  or  entity  (the
"Transaction").  Furthermore,  the Finder may introduce the Company to investors
who may,  at the  discretion  of the Company  and the  investor(s),  complete an
investment  transaction of which one or more  purchasers may be all or part of a
private placement offering  ("Offering").  The Offering and/or Transaction shall
be for equity  securities of the Issuer on terms and conditions  satisfactory to
the  Issuer.  As a result of the  introduction(s)  made by or through  Finder to
Issuer to an investor (either a single investor or several investors referred to
herein as "Investors") or any related entity under  Investors'  control,  should
all or any part of the Offering  and/or  Transaction be placed with Investors or
closed by the Issuer and the Target,  then Issuer  shall owe Finder such fees as
described herein on page 3. Should Issuer close on any introduction  pursuant to
a Transaction(s) under this Agreement,  that in itself shall serve as proof that
the  Offering  and/or  Transaction  met  the  terms  and  conditions  that  were
satisfactory to Issuer.

     2.2 Unless provided otherwise within this agreement,  it is acknowledged by
Issuer that:  Finder has acted solely as a finder and not in any other capacity;
Finder has not advised Issuer in any manner  regarding the merits of this or any
other  financing  arrangement,  acquisition,  merger,  joint  venture  or  other
business  arrangement;  Finder has  consulted  its own counsel on all aspects of
this Offering and/or  Transaction;  Finder has not made any  representations  to
Issuer to induce it into this  Agreement;  and Finder shall not sell or offer to
sell securities related to this Offering and/or Transaction.

                                       1
<PAGE>

         2.3 As it pertains to an  investment  or an  Offering,  Issuer shall be
under no  obligation to pay any fee or other monies to Finder on account of this
Agreement unless (a) the purchase of all or part of the Offering contemplated by
this Agreement has closed with Investors  and/or the Transaction has closed with
a Target. For purposes of this Agreement, the total amount of the fee due Finder
shall be due and  payable  on the date of the  closing  of the  Offering  and/or
Transaction. Issuer shall be under no obligation to consummate any such Offering
and/or  Transaction,  except upon such terms as shall be acceptable to Issuer in
its sole discretion.  However, if Issuer declines to accept such bona fide terms
as proposed to the Company by the Investor(s),  then the Finder has the right to
terminate  this  agreement and the Company will pay a fee of $0.00 to the finder
in  consideration  for the contacts and effort  provided by the finder to obtain
such terms and offers.

         2.4 Prior to the introduction to any particular investor and/or Target,
Finder will first disclose the identity of that proposed  Investor and/or Target
to the Issuer.  Issuer,  at its sole discretion,  can approve or decline whether
such introduction can be made to that Investor and/or Target. If Issuer does not
approve or decline whether such introduction can be made to that investor and/or
Target  within 24 hours of the  disclosure  of the identity of that investor and
/or Target by Finder to Issuer,  then such inaction shall be deemed an approval.
If the Investor or Target learns of the Issuer from the Finders Internet site or
any other  venue or forum  suggested  by the  Finder  and  contacts  the  Issuer
directly to pursue an investment or any  transaction  with the Issuer,  then the
Finder is required to be compensated as described in paragraph 2.1, 2.3 and 2.5.

         2.5 This  Agreement is for an initial  period of one year from the date
that the Issuer  indicates their approval by signing this agreement or so noting
electronically  by  responding  to  queries  over the  Finder's  Internet  site.
However, either party may cancel this agreement in writing within 30 days of the
expiration date of this initial one year period. If notification is not tendered
within this period than this agreement will  automatically  renew for another 12
month period from the expiration  date.  After this agreement has expired,  then
neither  party  will  have  any  obligations  towards  the  other  party  unless
previously   introduced  Investors  are  actively  negotiating  with  Issuer  at
expiration  time, then this Agreement will survive until such time as the active
dealings  either  terminate  or  an  Offering  and/or   Transaction  is  closed.
Furthermore,  if at any time in the future,  the Issuer  proceeds to transact an
offering  with any Investor  and/or target  introduced  by the Finder,  than the
finder will be  entitled  to collect  all of such fees as would  normally be due
within the provisions of this agreement.  All  introductions  made by the finder
will  continue to be  considered  introduction(s)  by the finder even after this
agreement has expired.

3. THE FEE

         3.1 The fee for  Acquisition  Services  as  hereinafter  defined as the
introduction  by Finder to Issuer of  Investors,  to be paid to Finder by Issuer
pursuant to this Agreement, shall be a sum computed as follows:

                                       2
<PAGE>

A.   _ Percent (_%), plus B. _ percent (_%) for unaccountable  expenses,  of all
     funds raised from the sale of Issuer securities to Investors as a result of
     the  introduction  of Investors to Issuer by Finder shall be paid to Finder
     in cash upon the  closing  of such  sale.  The term  "funds  raised"  shall
     include  all funds due to Issuer  under the  agreement  between  Issuer and
     Investors regardless of when those funds may be payable to Issuer.

--------------------------- -----------------------------------------
 Amount Funded                 A. Fee      B. Unaccountable Expenses
--------------------------- -----------------------------------------
  $1,000,000 to $5,000,000       5%                   2%
--------------------------- -----------------------------------------
 $5,000,001 to $10,000,000       4%                  1.5%
--------------------------- -----------------------------------------
$10,000,001 to $25,000,000       3%                  1.5%
--------------------------- -----------------------------------------
        $25,000,000 and up       2%                   1%
--------------------------- -----------------------------------------
          $0 to $1,000,000       10%                  3%
--------------------------- -----------------------------------------

B.   Plus, 10% of the  transaction  value in cashless  warrants of the Issuer on
     the same pricing and conditions as the Transaction or Issue warrants.

C.   In the event that the Finder  arranges a credit line or any  traditional or
     non traditional  bank debt  placement,  or an equity line with any Investor
     appropriate to provide this facility, then the Company can elect to pay the
     Finder 2% of the agreed upon total debt,  equity or credit  facility at the
     time of a closing for such facility.

                                       OR

D.   In the event that Finder  introduces  or identifies a business or entity to
     Issuer and Issuer  subsequently  acquires all or any portion of the capital
     securities  or assets of, or engages  in a merger,  joint  venture or other
     business  arrangement  with,  such  business  or entity  (the  "Acquisition
     Services"),   then  the  Issuer  will  compensate   Finder  (based  on  the
     Transaction  Value,  as defined below) for such services in an amount equal
     to:

              7% on the first $5,000,000 of the Transaction Value;
              6% on the amount from $5,000,001 to $10,000,000;
              5% on the amount from $10,000,001 to $15,000,000;
              4% on the amount from $15,000,001 to $20,000,000;
              3% on the amount from $20,000,001 to $25,000, 000, and
              3% on the amount in excess of $25,000,000.

E.   Plus, 10% of the  transaction  value in cashless  warrants of the Issuer on
     the same terms and conditions as the Transaction or Issue warrants.

                                       3
<PAGE>

           "Transaction  Value"  shall  mean the  aggregate  value of all
           cash,  securities and other  property (i) paid to Issuer,  its
           affiliates  or  their  shareholders  in  connection  with  any
           transaction  referred  to  in  this  paragraph  involving  any
           investment  in or  acquisition  of Issuer  or any of  Issuer's
           affiliates  (e.g.,  an entity that  directly,  or  indirectly,
           through one or more  intermediaries  controls or is controlled
           by, or is under common  control with Issuer) (or the assets of
           either), (ii) paid by or to the Issuer or any affiliate in any
           such transaction, or (iii) paid or contributed by Issuer or an
           affiliate  and by the other  party or  parties in the event of
           any such transaction involving a merger, consolidation,  joint
           venture or similar joint enterprise or undertaking.  The value
           of any such securities shall be the fair market value thereof,
           as determined in good faith by Issuer's Board of Directors and
           set  forth in the  relevant  acquisition  or other  applicable
           agreement.   If  Issuer   seeks   financing   in  addition  to
           acquisition  candidates,  then Issuer shall pay an  additional
           fee to the Finder for such service.

         3.2 The fee due to  Finder  shall be  payable  to  Finder  by Issuer at
closing and dispersed  from the closing  escrow.  The escrow agent shall release
the fee to Finder at the same time as the balance of escrowed funds are released
to  Issuer  and the  certificates  are sent to  Investors  and/or  Target or its
security  holders.  The Issuer is  responsible  for such fee and if the investor
refuses  to comply,  then the finder has the right to collect  such fee from the
Issuer immediately after a Transaction has occurred.

4. OTHER

     4.1  Unless  otherwise  arranged  between  the Issuer and the  Finder,  any
          arrangements made by Finder with any broker or other persons with whom
          Finder is or may be involved are the total  responsibility  of Finder.
          Upon  payment  made by Issuer to Finder of Finder's  fee,  Finder will
          hold Issuer free and  harmless  from any and all claims,  liabilities,
          commissions,  fees or expenses in connection with the transaction from
          any party who alleges a  relationship  with or through  Finder and the
          Investors and/or Target.

     4.2  Finder  will have the right to  publicize  its  relationship  with the
          Issuer and use any means it deems  necessary to attract  funds for the
          benefit of the Issuer,  including to advertise,  issue  correspondence
          through  traditional  and/or  electronic  methods,  or use  telephonic
          methods to promote the Issuer.  Once a transaction  is completed,  the
          Finder  will  have  the  right to  publicize  its  involvement  in the
          transaction and/or list a tombstone about the transaction.

     4.3 In the event of any dispute  between Issuer and Finder arising under or
pursuant to the terms of this Agreement,  or any matters arising under the terms
of this  Agreement,  the same shall be  settled  only by  arbitration  in Fulton
County,  City of  Atlanta,  State of  Georgia,  in  accordance  with  rules  and
regulations of the American  Arbitration  Association.  The determination of the
arbitrators  shall be final  and  binding  upon  Issuer  and  Finder  and may be
enforced in any court of appropriate jurisdiction.

                                       4
<PAGE>

         4.4 This Agreement shall be construed by and governed exclusively under
the laws of the  State of  Georgia,  without  regard  to its  conflicts  of laws
provisions.

         4.5 This  Agreement  contains the entire  agreement  between Finder and
Issuer  concerning  the  introduction  of Investors to Issuer and correctly sets
forth the rights and duties of each of the parties to each other concerning this
matter as of this date. Any agreement or  representation  concerning the subject
matter of this Agreement or the duties of Finder to Issuer in relation  thereto,
not set forth in this Agreement, is null and void.

         4.6 Issuer shall include in any  agreement  executed by Issuer with any
Investor and/or Target regarding the Offering and/or Transaction,  the following
representation:  "(the  Investor  and/or  Target)  has  performed  its  own  due
diligence  investigation  and has had the  opportunity  to ask questions of (the
Issuer) and its  management  team and analyze  their  responses.  (The  Investor
and/or  Target) has not relied on any  representations  not made by  (Issuer)and
expressly  set forth in the  purchase  agreement.  Both  parties to the purchase
agreement  shall release and hold harmless (the Finder) and from and against any
losses,   claims,   damages  or  liabilities  related  to  the  Offering  and/or
Transaction."

         4.7 Issuer shall include in any  agreement  executed by Issuer with any
Investor regarding the Offering and/or Transaction,  a covenant requiring Finder
to be paid its fees  hereunder  either from the funds held in escrow pending the
closing of the Offering and/or Transaction or directly from the Investors and/or
Issuer in accordance with the wiring instructions attached hereto as Exhibit A.

         4.8  Issuer  agrees to  indemnify  and hold  harmless  Finder  and each
person,  if any, who controls Finder within the meaning of the Securities Act of
1933, as amended (the "Act"),  its employees,  agents,  and the Finder's counsel
against any losses,  claims,  damages or  liabilities,  joint or several  (which
shall, for all purposes of this Agreement,  include,  but not be limited to, all
reasonable costs of defense and investigation and all attorneys' fees), to which
Finder, any controlling  person, its employees,  agents, or Finder's counsel may
become subject,  under the Act or otherwise,  insofar,  as such losses,  claims,
damages or liabilities  (or actions in respect  thereof) (i) arise out of or are
based upon any untrue statement or alleged untrue statement of any material fact
contained in the Offering and/or Transaction  documents and agreements;  or (ii)
arising out of or are based upon the  omission  or alleged  omission to state in
the  [Offering]  [Transaction]  documents  and  agreements  any  material  facts
required to be stated  therein or necessary to make the  statements  therein not
misleading.

                                       5
<PAGE>

IN WITNESS  WHEREOF,  the parties  have signed this  Agreement on the date first
written above.

Company: Nutrastar, Inc.
          (The "Issuer" or the "Company")

By: _______________________________

Title:______________________________

VSource1, Inc. and vSource1.com, Inc.
                 (The "Finder")

By:      Robert Gray
         Robert Gray
         President

                                       6Exhibit 10.10
                                LICENSE AGREEMENT

     This Agreement is made as of the 15 day of January 2002,  between The RiceX
Company, a Delaware  corporation  located at 1241 Hawk's Flight Court, El Dorado
Hills,   California  95762  (hereinafter  called   "Licensor"),   and  NutraStar
Technologies  Incorporated,  a Nevada corporation  located at 1261 Hawk's Flight
Court, El Dorado Hills, California 95762 (hereinafter called "Licensee").

                                    RECITALS

     A. Licensor and Licensee are parties to an exclusive distribution agreement
(the "Distribution Agreement") dated as of December 12, 2001 and agree that this
license  agreement  (the  "License  Agreement")  is entered into pursuant to the
Distribution  Agreement  and that the terms of the  Distribution  Agreement  are
hereby incorporated by reference into this License Agreement.

     B.  Licensor is the owner of the  trademarks  as defined  below and has the
exclusive right to license such trademarks.

     C.  Licensor  is the  owner of the  patents  as  defined  below and has the
exclusive right to license such patents.

     D. Both parties desire that Licensor  grant and Licensee  acquire a license
in, to and under Licensor's right,  title and interest in and to such trademarks
and patents upon the following terms and conditions,  which terms and conditions
shall govern the use by Licensee of such trademarks and patents.

     NOW,  THEREFORE,  in  consideration  of the  foregoing  and  of the  mutual
covenants and undertakings stated in the Distribution  Agreement and hereinafter
set forth, and the payment to Licensor of the royalties, fees, or other payments
set  forth  in  the   Distribution   Agreement   and  other  good  and  valuable
consideration  the  sufficiency of which the parties  acknowledge,  it is agreed
between the parties as follows:

1.  Definitions.  Capitalized terms shall have the meaning set forth below.

1.1 Combined  Products.  The term "Combined  Products"  shall mean any material,
composition,  ingredient,  or product that is the result of Licensee  adding to,
combining,  changing, modifying or otherwise utilizing any of the Products (with
the exception of the sale,  offer for sale,  marketing,  or  distribution of the
Products  by  themselves)   with   Licensee's   own   materials,   compositions,
ingredients, or other products.

1.2 Confidential Information. The term "Confidential Information" shall mean any
and all  proprietary or  confidential  information of Licensor or Licensee which
may be  exchanged  between  the parties at any time and from time to time during
the term of this License  Agreement or the Distribution  Agreement and which the
parties  have either  marked as  "Confidential"  or  conveyed  under the express

                                       1
<PAGE>

understanding  that such information is confidential.  Information  shall not be
considered confidential to the extent that it:

a. Is publicly disclosed through no fault of any party hereto,  either before or
after it becomes known to the receiving party; or

b. Was known to the receiving party prior to the Effective Date set forth in the
Distribution Agreement,  which knowledge was acquired independently and not from
the  disclosing  party  (or such  party's  employees),  to the  extent  that the
receiving party can show documentary evidence of such knowledge; or

c. Is  subsequently  disclosed to the  receiving  party in good faith by a third
party who has a right to make such disclosure; or

d. Has been published by a third party as a matter of right.

1.3 Field. The term "Field" shall mean the nutraceutical and human market.

1.4  Intellectual  Property.  The term  "Intellectual  Property"  shall mean the
Trademarks, Patents, Patent Rights, and Inventions collectively.

1.5  Inventions  The term  "Inventions"  shall  mean all  proprietary  technical
information,  software,  trade  secrets,  developments,  discoveries,  know-how,
methods, techniques, formulae, processes and other proprietary ideas, whether or
not patentable or copyrightable, that are conceived of, discovered, developed or
reduced to  practice,  in whole or in part,  by or for  Licensor  related to the
Products or Combined Products.

1.6 Patents.  The term "Patents" shall mean the patents  identified in Exhibit A
attached hereto and as set forth in Section 4(d) of the Distribution Agreement.

1.7 Patent Rights. The term "Patent Rights" shall mean all of Licensor's rights,
title and  interest  arising out of or  resulting  from (i) any and all U.S. and
foreign  patent  applications  and patents  covering  the  Inventions,  (ii) the
patents and patent applications  listed on Exhibit A attached hereto,  (iii) all
claims of  continuations-in-part  directed solely to subject matter specifically
described in the  Inventions,  and (iv)  divisionals,  continuations,  reissues,
reexaminations,  renewals and extensions of any patent or application  set forth
in (i)-(iii)  above,  so long as said patents have not been held invalid  and/or
unenforceable by a court of competent jurisdiction from which there is no appeal
or, if  appealable,  from  which no appeal  has been  taken.  Exhibit A shall be
amended  promptly by mutual  agreement of the parties as any  additional  Patent
Rights arise.

1.8 Products. For purposes of this License Agreement,  the term "Products" shall
collectively mean rice soluble and rice bran fiber  concentrate,  the "Products"
pursuant to the  Distribution  Agreement,  and all forms of the stabilized  rice
bran referred to in Section 2(a) and Exhibit A-1 of the Distribution Agreement.

                                       2
<PAGE>

1.9  Term.  The  "Term"  of this  License  Agreement  and the  licenses  granted
hereunder  shall  be for  the  same  period  as  the  term  of the  Distribution
Agreement.

1.10 Territory.  As set forth in Section 6 of the  Distribution  Agreement,  the
term  "Territory"  shall  mean  the  United  States  of  America  and all of its
territories  and any  additional  countries  or  regions of  countries  that the
parties mutually agree upon in writing.

1.11 Trademarks. As set forth in Section 4(c) of the Distribution Agreement, the
term  "Trademarks"  shall  mean the  "MIRACHOL(R),"  "MAXE(R),"  and  "RICEX(R)"
trademarks collectively.

2.  Trademark  License  Grant.  Licensor  hereby  grants  and agrees to grant to
Licensee, (i) the exclusive license,  including the right to sublicense pursuant
to the terms of Section  4.2  hereof,  in the  Territory  to use the  trademarks
"MIRACHOL(R)" and "MAXE(R)" in the Territory and (ii) the non-exclusive  license
to use the "RICEX(R)"  trademark in the Field during the Term.  Licensee  agrees
that the Trademarks  shall be used and displayed only in such form and manner as
shall be specifically approved by Licensor.

3. Patent License Grant.  Licensor hereby grants and agrees to grant to Licensee
the exclusive license,  including the right to sublicense  pursuant to the terms
of Section 4.3 hereof,  in the Territory and in the Field,  in, to and under all
of  Licensor's  right,  title and  interest  to and under the Patents and Patent
Rights,  to  import,  to use,  to offer  for  sale,  and to sell,  modify,  have
modified,  market,  and distribute  directly or indirectly and through  multiple
channels of distribution,  the Products and Combined  Products and to have those
rights exercised on its behalf, during the Term and subject to the provisions of
this License Agreement.

4.  License Terms and Conditions.

4.1 Display of the Trademarks.  Licensee is hereby required to imprint the RICEX
trademark brand on all Products or Combined  Products sold by Licensee  pursuant
to the Distribution Agreement.  In addition,  wherever and whenever possible and
applicable,  Licensee  is  hereby  required  to  affix  the  MIRACHOL  and  MAXE
trademarks  on  Products or Combined  Products.  Licensee is hereby  required to
imprint the applicable Trademarks to or on packaging, advertising,  promotional,
and all other  materials  sold,  used, or  distributed  in  connection  with the
Products or Combined  Products.  Licensee  hereby agrees to limit its use of the
Trademarks to the Territory and to the Products or Combined Products, packaging,
advertising, promotional, and other materials related thereto, all in accordance
with the foregoing and  according to quality  standards  approved by Licensor as
set forth in Section 4.7 hereof.

4.2 Sublicense of Trademarks.  Licensee's rights and obligations with respect to
the Trademarks  under this Agreement may not be sublicensed by Licensee  without
the prior written  consent of Licensor,  which consent shall not be unreasonably
withheld.  Upon  prior  written  consent  of  Licensor,  Licensee  may  grant  a
sublicense only for the performance of any acts to be performed by Licensee that
are contemplated  under this Agreement.  Any such sublicense shall be subject to
comparable applicable restrictions,  exceptions,  quality control,  termination,
confidentiality,  and other provisions contained in this License Agreement,  and
provided further,  that Licensee shall remain secondarily liable to Licensor for
the fulfillment of all of Licensee's obligations under this License Agreement.

                                       3
<PAGE>

4.3 Sublicense of Patents.  In the event Licensor is unable to provide  Licensee
with the quantity of Products  required by Licensee pursuant to the Distribution
Agreement and Licensor cannot cure such deficiency within sixty (60) days notice
of such  deficiency  from  Licensee at any time during this  License  Agreement,
Licensor hereby grants to Licensee the right to grant a sublicense in and to the
Patents,  Patent Rights, and Inventions to make or have Products made until such
time as the  deficiency  is cured by  Licensor.  Any  such  sublicense  shall be
subject to comparable  applicable  restrictions,  exceptions,  quality  control,
termination,  confidentiality,  and other  provisions  contained in this License
Agreement,  and provided further,  that Licensee shall remain secondarily liable
to Licensor for the  fulfillment  of all of  Licensee's  obligations  under this
License Agreement.

4.4 Title. All rights in the Intellectual Property other than those specifically
granted  herein are reserved to Licensor  for its own use and benefit.  Licensee
acknowledges  that it shall not acquire any rights of  whatsoever  nature in the
Intellectual Property as a result of Licensee's use thereof, and that all use of
the  Intellectual  Property by Licensee  shall inure to the benefit of Licensor.
Licensor  agrees that it shall not,  directly or indirectly,  during the term of
this License  Agreement or  thereafter,  attack the ownership by Licensor of the
Intellectual  Property  or the  validity  thereof or attack the  validity of the
license herein granted to it. Licensee recognizes that the Products are not sold
but, rather  licensed,  by Licensor to Licensee and that the price indicated for
the Products in the  Distribution  Agreement is a license fee and not a purchase
price.  All  right,  title,  and  interest  in  and to the  Products  and  other
intellectual  property  rights related  thereto at all times remain the sole and
exclusive property of Licensor.  Any modifications,  updates,  improvements,  or
adaptations to the  Intellectual  Property,  no matter by whom made or paid for,
shall remain the property of Licensor.  Upon Licensor's request,  Licensee shall
promptly  execute any documents  deemed  necessary or appropriate by Licensor to
confirm  said  ownership  of  such  modifications,   updates,  improvements,  or
adaptations to the Intellectual Property in Licensor.  Licensee shall not use or
authorize  the use of the  Intellectual  Property  in any  manner  other than as
specifically permitted under this License Agreement.

4.5  Unauthorized  Use. The license granted herein is granted solely to Licensee
and is not, by  implication  or otherwise,  granted to any partner,  subsidiary,
affiliate,  or  sublicensee  (except as otherwise set forth herein) of Licensee.
Licensee  shall not copy,  distribute,  reproduce,  use, or allow  access to the
Intellectual   Property  except  as  explicitly  permitted  under  this  License
Agreement and will not modify, adapt, prepare derivative works from , decompile,
reverse  engineer,  disassemble  or  otherwise  attempt to use the  Intellectual
Property in any manner not specifically authorized hereunder.

4.6 Licensee's  Diligence.  Licensee hereby acknowledges that Licensee shall use
it's best efforts to develop and manufacture the Products and Combined  Products
and that  Licensee  shall  use  it's  best  efforts  to sell,  offer  for  sale,
distribute,  import, market,  advertise,  and otherwise exploit the Products and
Combined Products.  In addition,  Licensee hereby acknowledges that it shall not
at any time  during the Term of this  License  Agreement  sell,  offer for sale,
distribute,  import,  market,  advertise,  or otherwise  exploit any material or
product  that  competes,  either  directly or  indirectly,  with any Products or

                                       4
<PAGE>

Combined  Products  hereunder.  At anytime  during  the Term,  in the event that
Licensee  fails to perform its  obligations  under this  Section 4.6 in the sole
discretion of Licensor for a period of ninety (90)  consecutive  days,  Licensor
shall have the right to terminate this License  Agreement with immediate  effect
upon written notice to Licensee.

4.7 Quality Control.  Licensor or its  representatives  shall have the right, at
all  reasonable  times,  to inspect the  Combined  Products  and any  marketing,
advertising,  packaging,  or other materials  related thereto  (collectively the
"Goods").  Licensee agrees to establish  quality standards and shall submit such
standards to Licensor for Licensor's  approval.  Licensee agrees to: comply with
those quality standards  approved by Licensor and maintain a level of quality in
the Goods so that such Goods as of the date of sale or other  distribution shall
be of good and merchantable  quality and fit for the purpose for which the Goods
are sold or otherwise  distributed and will meet all applicable federal,  state,
local, and  international  laws,  rules and regulations;  to remedy such quality
deficiencies as Licensor or its representatives may find and bring to Licensee's
attention; and upon request by Licensor, to provide samples of the Trademarks in
use to assist Licensor in maintaining  quality control.  If Licensor  reasonable
determines  that such  Goods are not of the level of  quality  required  by this
License  Agreement,  Licensee  shall make such  modifications  to the use of the
Intellectual  Property as  reasonably  requested by Licensor.  In the event that
Licensee  fails to make  such  modifications  for a period of sixty  (60)  days,
Licensor may terminate this License Agreement pursuant to Section 9.2 hereof.

4.8 Foreign  Registration.  Licensee  agrees to register this License  Agreement
with any applicable foreign governmental agency that requires such registration,
and Licensee  shall pay all costs and legal fees in  connection  therewith,  and
such  registration  shall not be considered a violation of Section 5 hereof.  In
addition,  Licensee  shall  be  responsible  for  satisfying  all  foreign  laws
affecting this License Agreement and the sale of Products, Combined Products, or
other materials  associated therewith which Licensee sells outside of the United
States.

5.  Intellectual Property Administration.

5.1  Intellectual  Property  Prosecution  and  Maintenance.  Licensor shall have
responsibility for and prepare all application filings,  prosecution  documents,
provide all maintenance and Licensee shall pay all fees and expenses,  including
legal fees,  relating  to the  Intellectual  Property.  Licensee  shall  provide
Licensor  with all  information  in its  possession  necessary or useful for the
filing and prosecution of such  Intellectual  Property and shall cooperate fully
with Licensor so that Licensor may establish and maintain such rights. Attorneys
chosen by  Licensor  shall  handle all  filings  and  prosecutions  on behalf of
Licensor. In the event Licensor declines to prepare necessary documents and fees
to apply for, prosecute or maintain any of the Intellectual  Property,  Licensee
shall have the right to pursue the same at Licensee's  expense.  Licensor  shall
give sufficient and timely notice to Licensee of its decision not to prepare the
necessary   documents  and  fees  to  apply  for,   prosecute  or  maintain  any
Intellectual  Property  so as to permit  Licensee  to apply for,  prosecute  and
maintain  such  Intellectual  Property.  In such event,  Licensor  shall provide
Licensee with all information necessary or useful for the filing and prosecution
of such  Intellectual  Property and shall  cooperate fully with Licensee so that
Licensee may establish and maintain such rights.

                                       5
<PAGE>

5.2 Power of  Attorney.  In the event that either party is unable to provide the
necessary  cooperation required to file, maintain, or prosecute the Intellectual
Property  pursuant  to  Section  5.1  hereof,   each  party  hereby  irrevocably
designates  and  appoints  the other party and its  officers  and agents as it's
agent and  attorney in fact,  to act for and in it's behalf and stead to execute
and file any such  applications  and  documents,  and to do all  other  lawfully
permitted  acts to further  the  prosecution  and  issuance  of letters  patent,
copyright,  or trademark  registrations or transfers thereof with the same legal
force and effect as if executed by the other party.

5.3  Intellectual  Property  Marking.  To the extent required by applicable law,
Licensee shall mark or require its  sublicensees  or other third parties to mark
all Products or Combined  Products or their  containers in  accordance  with the
applicable marking laws affecting the Intellectual Property.

5.4 Foreign  Registration.  Licensee  agrees to register this License  Agreement
with any applicable foreign governmental agency that requires such registration,
and Licensee  shall pay all costs and legal fees in  connection  therewith,  and
such  registration  shall not be  considered  a  violation  of Section  5.1.  In
addition,  Licensee  shall  be  responsible  for  satisfying  all  foreign  laws
affecting  its sale of  Products  or  Combined  Products  outside  of the United
States.

6.  Infringement Actions.

6.1 Prosecution and Defense of Infringements.  Each party shall promptly provide
written notice to the other of any suspected  infringement  of any claims in the
Intellectual  Property,  or  misuse,   misappropriation,   theft  or  breach  of
confidence of other proprietary  rights in the Intellectual  Property by a third
party  of  which  it is  aware.  Licensor  shall  have  the  right,  but not the
obligation,  to prosecute any and all infringements of any Intellectual Property
and to defend all charges of infringement arising as a result of the exercise of
Licensor's  rights  by  Licensee,  its  sublicensees,  or other  third  parties.
Licensor may enter into settlements,  stipulated judgments or other arrangements
respecting  such  infringement,  at its own  expense,  but only  with the  prior
written consent of Licensee,  which consent shall not be unreasonably  withheld.
Licensee  shall  permit any action to be brought in its name if required by law,
and Licensor shall hold Licensee harmless from any costs,  expenses or liability
respecting all such infringements or charges of infringement. Licensee agrees to
provide  reasonable  assistance  that  Licensor  may  require in any  litigation
arising in  accordance  with the  provisions of this License  Agreement.  In the
event  Licensor  fails to  prosecute  any such  infringement  within a period of
ninety (90) days after receiving  notice or otherwise  having  knowledge of such
infringement,  then Licensee shall have the right to prosecute such infringement
on its own behalf.

6.2 Allocation of Recovery.  Any damages or other recovery from an  infringement
action  undertaken  by either party  pursuant to Section 6.1: (i) shall first be
used to  reimburse  the  parties  for the costs and  expenses  incurred  in such
action,  and shall thereafter be allocated between the parties as follows,  (ii)
shall be allocated pro rata to the parties in an amount equal to the damages and
expenses  actually  incurred by each,  (iii) then any remainder  amount shall be
remitted to the party undertaking the infringement action.

                                       6
<PAGE>

7.  Warranties, Indemnifications, and Limitations of Liability.

7.1 Authority. Each party warrants and represents to the other party that it has
the requisite  authority,  ability,  and capabilities to enter into this License
Agreement and to perform all of its obligations thereunder.

7.2 Licensee  Commercialization.  Licensee  warrants and  represents to Licensor
that Licensee has sufficient  capacity to manufacture the Combined  Products and
sell, offer for sale, market, advertise, distribute, and import the Products and
Combined  Products,  and otherwise  fulfill its  obligations  under this License
Agreement with respect to the exploitation and commercialization of the Products
and Combined Products.

7.3 Manufacturing Standard. Each party represents and warrants that the products
it manufactures shall be manufactured in a workmanlike manner, shall comply with
then current industry standards and will be free from defects in workmanship.

7.4 Consents and No Pending  Matters.  Each party hereby  represent and warrants
that (i) it has the full right,  power, and authority to enter into and be bound
by all of the terms and conditions of this License  Agreement,  and to carry out
all of it's obligations  under this License  Agreement,  without the approval or
consent of any other person or entity,  (ii) the  entering  into of this License
Agreement,  and the carrying out of that party's  obligations under this License
Agreement is not  prohibited,  restricted or otherwise  limited by any contract,
agreement or understanding entered into by that party, or by which that party is
bound,  with any other person or any  governmental  authority  or entity,  (iii)
there is no contract, agreement, understand or judgment entered into by a party,
or by which that party is bound,  which if  enforced,  terminated,  or modified,
would be in derogation  of,  contrary to, or adversely  affect any of the rights
acquired  or to be  acquired  hereunder  by either  party,  and (iv) there is no
action,  suit,  proceeding,  or  investigation  pending or currently  threatened
against  either party which,  if adversely  determined,  would restrict or limit
that party's right to enter into and be bound by this License Agreement.

7.5      Insurance and Indemnifications.

     (a)  Each of the  parties  shall  be  responsible  for its own  errors  and
omissions and shall indemnify, defend, and hold harmless the other party and the
other party's shareholders,  directors, officers, employees, agents, affiliates,
successors, sublicensees, and assigns (collectively, the "Indemnitees"), against
and from all claims  and  losses  incurred,  suffered  by, or  imposed  upon the
Indemnitees and arising out of the indemnifying party's own activities,  acts or
omissions, except to the extent due to the negligent acts or omissions,  willful
misconduct,   recklessness   of,  or  violation  of  applicable   laws  by,  the
Indemnitees.  In furtherance thereof,  each party shall defend,  indemnify,  and
hold harmless the other and its shareholders,  directors,  officers,  employees,
agents, affiliates,  successors, and assigns (collectively,  the "Indemnitees"),
against and from all claims and losses  incurred,  suffered  by, or imposed upon
the  Indemnitees  to the  extent  arising  out of any breach of any of the other
party's covenants, representations and warranties under this Agreement.

                                       7
<PAGE>

         (b) Licensee  shall obtain and maintain a product  liability  insurance
policy with  coverage in an amount  equal to Five Million  Dollars  ($5,000,000)
naming Licensor as an additional insured.

         (c) Licensee agrees to defend,  indemnify,  and hold Licensor  harmless
against any loss,  liability,  damage,  cost, or expense  (including  reasonable
legal costs and fees) arising out of any claims or suits,  whatever their nature
and however arising,  which may be brought or made against Licensor by reason of
or   arising   from  (i)  any  breach  of  any  term,   condition,   obligation,
representation,  or  warranty  of  this  Agreement  by  Licensee;  or  (ii)  any
allegation of product  liability or personal  injury arising from or relating to
the Combined  Products or other  products or  materials of Licensee  that differ
from the  Products  in the form and manner  provided  by Licensor to Licensee or
arising from the development,  testing,  manufacture, use, sale, offer for sale,
importation, exportation, storage, handling, transportation, distribution or any
other disposition of any Product or Combined Product and other materials related
thereto  conducted  by Licensee.  In no event may Licensee  enter into any third
party  settlement  agreements  which would in any manner  whatsoever  affect the
right of, or bind, Licensor in any manner to said third party, without the prior
written consent of Licensor.

7.6 Limited  Warranty.  Licensor hereby represents and warrants that it has full
right and power to enter into this License  Agreement.  LICENSOR  MAKES NO OTHER
WARRANTIES  OTHER THAT THOSE  EXPRESSLY  PROVIDED FOR HEREIN.  LICENSOR MAKES NO
EXPRESS OR IMPLIED  WARRANTY  OF  MERCHANTABILITY  OR FITNESS  FOR A  PARTICULAR
PURPOSE AS TO LICENSOR'S  INTELLECTUAL PROPERTY RIGHTS OR ANY PRODUCT.  LICENSOR
MAKES NO WARRANTY OR  REPRESENTATION  AS TO THE VALIDITY OR SCOPE OF  LICENSOR'S
INTELLECTUAL  PROPERTY RIGHTS,  RELATED TECHNOLOGY,  OR THAT ANY PRODUCT WILL BE
FREE FROM AN  INFRINGEMENT ON PATENTS OR OTHER  INTELLECTUAL  PROPERTY RIGHTS OF
THIRD PARTIES.

7.7 Merchantability. TO THE MAXIMUM EXTENT PERMITTED BY APPLICABLE LAW, LICENSOR
DISCLAIMS ALL OTHER  WARRANTIES,  EITHER  EXPRESS OR IMPLIED,  INCLUDING BUT NOT
LIMITED TO IMPLIED  WARRANTIES OF TITLE,  NONINFRINGEMENT,  MERCHANTABILITY  AND
FITNESS FOR A PARTICULAR PURPOSE, WITH RESPECT TO THE PRODUCTS.

7.8 Limits on Liability. Licensor's liability for damages of any kind is limited
to any amounts  paid to Licensor by Licensee  under the  Distribution  Agreement
during the year in which the damages occur.

IN NO EVENT SHALL EITHER PARTY BE LIABLE FOR INCIDENTAL, SPECIAL, CONSEQUENTIAL,
OR PUNITIVE DAMAGES,  INCLUDING,  BUT NOT LIMITED TO LOST REVENUE OR PROFITS, IN
CONNECTION WITH THIS AGREEMENT OR ITS BREACH,  OR ARISING FROM THE  RELATIONSHIP
OF THE PARTIES OR THE CONDUCT OF BUSINESS BETWEEN THEM, EVEN IF EITHER PARTY WAS
ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.

                                       8
<PAGE>

8.  Confidentiality.

8.1  Treatment of  Confidential  Information.  The parties agree that during the
Term and so long as the Confidential  Information  under this License  Agreement
remains confidential after this License Agreement terminates,  a party receiving
Confidential Information of the other party will (i) maintain in confidence such
Confidential  Information  to the  same  extent  such  party  maintains  its own
proprietary  industrial  information,  and in any event not less than reasonable
care, (ii) not disclose such Confidential Information to any third party without
prior written  consent of the other party,  and (iii) not use such  Confidential
Information  for any purpose except those  permitted by this License  Agreement.
For the purposes of this License Agreement,  Confidential  Information is deemed
to include  (but not be  limited  to) all  unpatented  Licensor  Inventions,  or
Licensee   technology   that  have  been  disclosed  to  Licensor  or  Licensee.
Notwithstanding  the foregoing,  it shall not be a violation of this Section 8.1
for a receiving party to disclose  Confidential  Information that is required to
be  disclosed  by  order  of the US Food  and  Drug  Administration  or  similar
authority or a court of competent jurisdiction,  which order is final and cannot
be appealed;  provided  that the parties will  coordinate  their best efforts to
obtain  confidential  treatment of such  information  by the agency or court and
provided  that  the  parties  will  coordinate  their  best  efforts  to  obtain
confidential  treatment of such information by the agency or court, and that the
receiving  party  gives  prior  written  notice to the  disclosing  party of the
proposed  disclosure and cooperates  fully with the disclosing party to minimize
the  scope  of any such  required  disclosure,  to the  extent  possible  and in
accordance with applicable law.

8.2 Publicity.  Except as otherwise provided herein or required by law, no party
shall  originate  any  publication,  news release or other public  announcement,
written  or  oral,  whether  in the  public  press,  stockholders'  reports,  or
otherwise, relating to this License Agreement or to any sublicense hereunder, or
to the performance  hereunder or any such agreements,  without the prior written
approval of the other party, which approval shall not be unreasonably withheld.

9.  Termination.

9.1  Termination  Upon  Default.  The failure of a party to perform any material
obligation  required of it to be  performed  hereunder,  and the failure to cure
such failure within sixty (60) days after receipt of notice from the other party
specifying  in  reasonable  detail  the  nature of such  material  breach  shall
constitute an event of default  hereunder.  Upon the occurrence of such material
default,  the  non-defaulting  party may deliver to the defaulting party written
notice of intent to terminate,  such  termination  to be effective upon the date
set forth in such notice, subject to the provisions of Section 10.10 hereof. The
termination rights hereunder shall be in addition to and not in substitution for
any  other  remedies  that  may  be  available  to  the  non-defaulting   party.
Termination  pursuant to this Section 9.1 shall not relieve the defaulting party
from  liability  and  damages  to the  other  party for  breach of this  License
Agreement.  Waiver  by  either  party of a single  default  or a  succession  of
defaults  shall not deprive  such party of any right to  terminate  this License
Agreement arising by reason of any subsequent default.

9.2  Termination  Upon Bankruptcy or Insolvency.  This License  Agreement may be
terminated by Licensor giving written notice of termination to Licensee upon the
filing of bankruptcy or bankruptcy of Licensee or the  appointment of a receiver
of any of Licensee's assets, or the making by Licensee of any assignment for the

                                       9
<PAGE>

benefit of creditors,  or the  institution of any proceedings  against  Licensee
under any bankruptcy law, provided that Licensee has not obtained a dismissal of
such  action  or  any  related   proceedings  within  sixty  (60)  days  of  the
commencement thereof.

9.3 Rights Upon  Expiration.  Neither  party  shall have any  further  rights or
obligations  upon the  expiration of this License  Agreement  upon its regularly
scheduled expiration date with respect to this License Agreement, other than set
forth otherwise herein.

9.4 Rights Upon Termination.  Upon  termination,  Licensee shall have no further
right to develop, manufacture, distribute, market, or otherwise commercialize or
exploit any Product or Combined  Product,  or to otherwise use any of the Patent
Rights,  Trademarks,  or  Inventions  not  otherwise  includable  therein.  Upon
termination,  Licensee  shall  promptly  return  all  Confidential  Information,
materials,  samples, documents,  information, and other materials that embody or
disclose the Trademarks,  Patent Rights, or Inventions not otherwise  includable
therein.  Any  termination  shall not relieve either party from any  obligations
accrued to the date of such termination.

9.5 Effect of Expiration or Termination.  The following provisions shall survive
the expiration or termination of this License Agreement:  Sections 4.4, 5, 6, 7,
8, and 10.

10.  General Provisions.

10.1 Contractual  Conflict.  In the event a conflict exists between the terms of
the Distribution Agreement and the terms of this License Agreement, the terms of
the Distribution  Agreement shall control,  except when the conflict is directly
related to the use and  restrictions  on use with  respect  to the  Intellectual
Property, in that event, the terms of this License Agreement shall govern.

10.2  Governmental  Approval.  Licensee shall obtain all necessary  governmental
approvals for the manufacture, use, sale, offer for sale, distribution,  import,
marketing,  advertising  and other  exploitation  of the  Products  and Combined
Products.

10.3 Independent  Contractors.  The relationship  between the parties is that of
independent  contractors.   Licensor  and  Licensee  are  not  joint  venturers,
partners,  principal and agent,  master and servant,  employer or employee,  and
have no other relationship other than independent contracting parties.  Licensor
and Licensee  shall have no power to bind or obligate  each other in any manner,
other than as is expressly set forth in this License Agreement.

10.4  Arbitration.  All disputes,  controversies,  and claims  arising out of or
related to this License Agreement (except  disputes,  controversies,  and claims
relating  to  or  affecting   Licensor's   ownership  or  the  validity  of  any
Intellectual  Property  or  any  registration  thereof)  shall  be  settled  and
determined by  arbitration  in Sacramento,  California,  U.S.A.  before a single
arbitrator  in accordance  with and pursuant to the then existing  International
Arbitration  Rules of the American  Arbitration  Association  incorporating  the
rules of  discovery  of the  State  of  California.  The  arbitrator  may  award

                                       10
<PAGE>

reasonable  attorney's  fees  and  expenses  to  the  prevailing  party  of  any
arbitration.  The  parties  specifically  waive  all  rights to any  claims  for
punitive damages against each other.

10.5 Entire Agreement;  Modification.  Any rights and obligations  arising under
this License Agreement may not be assigned by Licensee without the prior written
consent of Licensor.  This License Agreement sets forth the entire agreement and
understanding between the parties as to the subject matter hereof and supercedes
all prior or contemporaneous agreements or understandings as between the parties
relating to their subject matter.  There shall be no amendments or modifications
to this License Agreement, except by a written document, which is signed by both
parties.

10.6  Headings.  The  headings  for each  article  and  section in this  License
Agreement  have been  inserted for  convenience  of  reference  only and are not
intended  to limit or expand on the  meaning of the  language  contained  in the
particular article or section.

10.7  Severability.  Should any one or more of the  provisions  of this  License
Agreement be held invalid or unenforceable by a court of competent jurisdiction,
it shall be considered  severed from this License  Agreement and shall not serve
to invalidate the remaining provisions thereof.

10.8 No Waiver.  Any delay in  enforcing  a party's  rights  under this  License
Agreement  or any waiver as to a  particular  default or other  matter shall not
constitute  a waiver of such  party's  rights to the future  enforcement  of its
rights under this License Agreement, excepting only as to an express written and
signed waiver signed by the party against whom such waiver is being  enforced as
to a particular matter for a particular period of time.

10.9 Name.  Whenever there has been an assignment or a sublicense by Licensee as
permitted by this License Agreement, the reference to "Licensee" as used in this
License Agreement shall also include and refer to, if appropriate, such assignee
or sublicensee.

10.10  Notices.  Any notices  required  by this  License  Agreement  shall be in
writing, shall specifically refer to this License Agreement and shall be sent by
registered or certified airmail, postage prepaid, or by telefax, telex or cable,
charges prepaid, or by overnight courier, postage prepaid and shall be forwarded
to the  respective  addresses  set forth below  unless  subsequently  changed by
written notice to the other party:

For Licensor:

The RiceX Company
1241 Hawk's Flight Court
El Dorado Hills, California 95762
Attn: Chief Executive Officer
Phone No. 916 933-3000
Fax No. 916 933-3232

                                       11
<PAGE>

and a copy to:

Crosby, Heafey, Roach & May
1901 Avenue of the Stars, Suite 700
Los Angeles, California 90067
Attention: Richard W. Lasater II, Esq.
Phone No. 310 734-5200
Fax No.: 310 734-5299

For Licensee:

NutraStar Technologies Incorporated
1261 Hawk's Flight Court
El Dorado Hills, California 95762
Attn: Chief Executive Officer
Phone No. 916 933-7000
Fax No. 916 933-7001

Notice shall be deemed  delivered  upon the earlier of (i) when  received,  (ii)
three (3) days after deposit into the mail, or (iii) the date notice is sent via
telefax,  telex  or  cable,  (iv)  the day  immediately  following  delivery  to
overnight courier (except Sunday and holidays).

10.11  Compliance with U.S. Laws.  Nothing  contained in this License  Agreement
shall require or permit Licensor or Licensee to do any act inconsistent with the
requirements of any United States law, regulation or executive order as the same
may be in effect from time to time.

10.12 Force Majeure.  Neither party shall be held  responsible  for any delay or
failure  in  performance  hereunder  caused by  strikes,  embargoes,  unexpected
government requirements, civil or military authorities, acts of God, earthquake,
or by the public enemy or other causes  reasonably  beyond such party's  control
and without such party's fault or negligence.  In the event that a force majeure
event as described in this Section  10.12  subsists and remains  unresolved  for
more  than  ninety  (90)  days from the date  such  event  arose,  the party not
affected or delayed by the event shall have the right to terminate  this License
Agreement upon thirty (30) days written notice to the affected party.

10.13  Governing Law. This License  Agreement shall be construed and enforced in
accordance  with  the laws of the  State of  California  without  regard  to the
conflicts of laws principles thereof.

                                       12
<PAGE>

IN WITNESS  WHEREOF,  the parties have executed this License  Agreement by their
duly authorized representatives as of the date set forth above.

LICENSOR:                          LICENSEE:

THE RICEX COMPANY                   NUTRASTAR TECHNOLOGIES INCORPORATED
INCORPORATED

By:_____________________________    By:___________________________

Title:___________________________   Title:_________________________

Date:___________________________    Date:_________________________

                                       13
<PAGE>

                                   SCHEDULE A

Patents:

     Patent  No.   6,126,943   "A  Method  for   Treating   Hypercholesterolmia,
     Hyperlipidemia, and Atherosclerosis," published October 3, 2000

     Patent No. 6,303,586 "A Method for Treating  Diabetes,  Hyperglycemia,  and
     Hypoglycemia," published October 16, 2001

     Serial No. 09/624,474 "A Method for Treating Diabetes,  Hyperglycemia,  and
     Hypoglycemia," allowed on October 2, 2001

                                       14

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00055-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00055-of-00352.parquet"}]]